David Cella
- Oncology top 0.01%
- Cancer survivorship and care 351
- Cancer Treatment and Pharmacology 85
-
- Childhood Cancer Survivors' Quality of Life 209
- Pulmonary and Respiratory Medicine top 0.01%
- Renal cell carcinoma treatment 83
- Otorhinolaryngology top 0.05%
- Hematology top 0.05%
-
- Health Systems, Economic Evaluations, Quality of Life 202
- Economic and Financial Impacts of Cancer 108
-
- Palliative Care and End-of-Life Issues 92
-
- Family Support in Illness 80
- Co-authors
- Ron D. HaysDennis A. RevickiJin‐Shei LaiKimberly WebsterDavid S. TulskyS B YellenAmy H. PetermanAmy E. Bonomi
- Journals
- Journal of Clinical Oncology (168 papers)Quality of Life Research (99 papers)Value in Health (60 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
David Cella
1.3k papers receiving 92.5k citations
Hit Papers
Peers
Comparison fields: 5 of 214
- Oncology 37.1k
- Pediatrics, Perinatology and Child Health 15.4k
- Pulmonary and Respiratory Medicine 18.5k
- Otorhinolaryngology 2.5k
- Hematology 6.2k
Countries citing papers authored by David Cella
This map shows the geographic impact of David Cella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cella more than expected).
Fields of papers citing papers by David Cella
This network shows the impact of papers produced by David Cella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cella. The network helps show where David Cella may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Cella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 5 | |
| 11 | 2021 | 20 | |
| 12 | 2020 | 11 | |
| 13 | 2017 | 144 | |
| 14 | 2016 | 65 | |
| 15 | 2014 | 18 | |
| 16 | Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trialbreakdown → | 2011 | 604 |
| 17 | 2009 | 378 | |
| 18 | 2009 | 213 | |
| 19 | 2007 | 127 | |
| 20 | 2005 | 1 |
About David Cella
David Cella is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Economics and Econometrics, having authored 1.3k papers that have together received 95.1k indexed citations. Recurring topics across this work include Cancer survivorship and care (351 papers), Childhood Cancer Survivors' Quality of Life (209 papers), Health Systems, Economic Evaluations, Quality of Life (202 papers), Economic and Financial Impacts of Cancer (108 papers), Palliative Care and End-of-Life Issues (92 papers), Cancer Treatment and Pharmacology (85 papers), Renal cell carcinoma treatment (83 papers) and Family Support in Illness (80 papers). The work is most often cited by research in Oncology (37.1k citations), Pediatrics, Perinatology and Child Health (15.4k citations) and Pulmonary and Respiratory Medicine (18.5k citations). David Cella has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Ron D. Hays, Dennis A. Revicki, Jin‐Shei Lai, Kimberly Webster, David S. Tulsky, S B Yellen, Amy H. Peterman, Amy E. Bonomi, Seung W. Choi and Karon F. Cook. Their work appears in journals such as Journal of Clinical Oncology, Quality of Life Research, Value in Health, Cancer and Journal of Pain and Symptom Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.